We are live on
!
Find out more
ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
1-Year Est. Return
8.06%
This Fund
S&P 500
This Quarter
Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$42.1M
(+12%)
Cap. Flow
+$6.1M
Cap. Flow
% of AUM
1.59%
Top 10 Holdings %
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franco-Nevada
FNV
|
+$3.64M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$2.27M |
| 3 |
Gilead Sciences
GILD
|
+$1.9M |
| 4 |
Seacoast Banking Corp of Florida
SBCF
|
+$1.75M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$1.7M |
| 2 |
NVIDIA
NVDA
|
+$477K |
| 3 |
Energy Transfer Partners
ET
|
+$408K |
| 4 |
IBM
IBM
|
+$398K |
| 5 |
McDonald's
MCD
|
+$344K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 14.79% |
| 3 | Consumer Staples | 13.71% |
| 4 | Miscellaneous | 12.81% |
| 5 | Financials | 12.5% |
Similar funds
BPM
S
ACM
GMA
AW
RFA
AIA
SMG
American Research & Management Company's Q4 2020 Portfolio in Review
As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
- American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
- American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
- American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
- American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
- American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
- American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
- American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.
Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.